Results 61 to 70 of about 1,395 (139)

Esophageal abnormalities in juvenile localized scleroderma: is it associated with other extracutaneous manifestations?

Revista Brasileira de Reumatologia
Objective: To assess esophageal involvement (EI) in juvenile localized scleroderma (JLS) population and the possible association between this gastrointestinal manifestation and demographic data, clinical features, laboratory exams, treatments and ...
Clarissa C.M. Valões, Glaucia V. Novak, Juliana B. Brunelli, Katia T. Kozu, Ricardo K. Toma, Clovis A. Silva   +5 more
doaj   +1 more source

Juvenile Localized Scleroderma: A Very Rare Case

Delta Medical College Journal, 2015
Juvenile localized scleroderma (JLS) is a rare chronic inflammatory and fibrosing disorder. It can result in significant morbidity, disfigurement, and severe functional, aesthetic and psychological disabilities. Patients with JLS should be identified early, evaluated extensively, treated aggressively, and monitored carefully.
Md Mahamudul Hasan, Lazina Sharmin, Nadia Nusrat, Md Rafiqul Islam, Nibedita Paul   +4 more
openaire   +2 more sources

Efektivitas Metotreksat sebagai Terapi pada Anak dengan Sistemik Sklerosis

Sari Pediatri
Latar belakang. Sklerosis sistemik juvenil pada anak (JSSc) merupakan penyakit jaringan ikat multisistem, kronis, dan autoimun yang menyerang anak-anak
Charity Cesilia Tololiu, Raynald Oktafianus Takumansang, Diana Devi Sondakh   +2 more
doaj   +1 more source

The Importance of the Skin Syndrome in the Primary Diagnosis of Connective Tissue Diseases in Children: Case Report

Педиатрическая фармакология
Background. Timely verification of the clinical diagnosis of connective tissue diseases in children based on the onset of the earliest symptoms, including skin manifestations, and timely initiation of treatment can prevent the development of irreversible
Anastasia O. Zatolokina, Tamara V. Belousova, Svetlana A. Loskutova, Nataliya E. Blagitko   +3 more
doaj   +1 more source

Recent Advances in Localized Scleroderma

Sclerosis
Localized scleroderma (LSc), or morphea, is an autoimmune connective tissue disease causing inflammation and fibrosis of the skin and underlying tissues. While distinct from systemic sclerosis, its clinical presentation is highly diverse.
Toshiya Takahashi, Takehiro Takahashi, Yoshihide Asano   +2 more
doaj   +1 more source

Articular involvement in juvenile localized scleroderma [PDF]

MOJ Orthopedics & Rheumatology, 2018
Osminina MK, Geppe NA, Shpitonkova OV
openaire   +1 more source

UEG Week 2025 Poster Presentations

United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley   +1 more source

Abstract

JPGN Reports, Volume 6, Issue S2, Page S1-S814, September 2025.
wiley   +1 more source

Juvenile Localized Scleroderma [PDF]

, 2020
openaire   +1 more source

Methotrexate and Mycophenolate Mofetil and Clinical Response in Juvenile Localized Scleroderma

JAMA Dermatology
Importance Currently, there are no treatments approved by the US Food and Drug Administration for juvenile localized scleroderma (JLS), a rare disease. While methotrexate (MTX) is regularly used as a first-line therapy, emerging data from case series and applications in systemic sclerosis suggest that ...
de Rosas, Elena C., Wang, Justin C., Zigler, Christina K., Torok, Kathryn S.   +3 more
openaire   +2 more sources